Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Qianli Technology(601777.SH) announced its 2025 annual performance, with net profit attributable to shareholders of 84.41 million yuan, a year-on-year increase of 110.93%.
Zhitong Finance APP news: Qianli Technology (601777.SH) has released its 2025 annual report. During the reporting period, the company achieved revenue of 10B yuan, up 42.13% year over year; net profit attributable to shareholders of the parent company was 84.41 million yuan, up 110.93% year over year; non-recurring items excluded net profit was a loss of 255 million yuan, with a year-over-year increase in the deficit; basic earnings per share were 0.02 yuan.
Operating revenue grew 42.13% compared with the same period last year. This was mainly due to higher sales volume in the automotive business and motorcycle business, which drove an increase in revenue.
Net profit attributable to shareholders of the listed company grew 110.93% compared with the same period last year. This was mainly due to an increase in revenue from the main business, which led to an increase in profit. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses declined compared with the same period last year. This was mainly due to the addition of technology businesses, the expansion of the R&D personnel scale, an increase in R&D investment, an increase in impairment losses on assets accrued, and an increase in deferred income tax expenses.